RED RICE BRAN EXTRACT SUPPRESSES COLON CANCER CELLS VIA APOPTOSIS INDUCTION/CELL CYCLE ARREST AND EXERTS ANTIMUTAGENIC ACTIVITY
DOI:
https://doi.org/10.15407/exp-oncology.2023.02.220Keywords:
colon cancer cells, apoptosis, cell cycle arrest, antimutagenicity, red rice bran extractAbstract
Background. Red rice bran extract (RRBE) contains many biologically active substances exerting antioxidant and anti-inflammatory effects. Aim. To evaluate the anticancer potential of RRBE in human colon cancer cells and its mutagenic/antimutagenic effects on nonmalignant cells. Materials and Methods. The cytotoxic effect of RRBE was determined by trypan blue exclusion in HCT116, HT29 cell lines and a non-cancerous HEK293 cell line, and its antiproliferative effect using MTS and colony formation assay. The apoptosis induction was evaluated using ELISA, and the apoptotic rate and cell cycle progression were assessed by flow cytometry. The mutagenic/ antimutagenic potential of RRBE was analyzed by micronucleus assay in the V79 cell line. Results. RRBE caused a dose-dependent reduction of cell viability in colon cancer cells and showed a limited cytotoxicity against HEK293 cells. The treatment with RRBE suppressed proliferation of HCT116 and HT29 cells and induced apoptosis as evidenced by the increased DNA fragmentation and the apoptotic cell counts. Furthermore, RRBE treatment significantly increased the number of cells at the G2/M phase triggering the arrest of the cell cycle in colon cancer cells. Interestingly, RRBE did not increase the micronucleus frequency in V79 cells but reduced the micronucleus formation caused by mitomycin C. Conclusion. RRBE effectively suppressed proliferation, induced apoptosis, and caused a cell cycle arrest in human colon cancer cells while being non-mutagenic and exerting antimutagenic effects in vitro.
References
Tyagi A, Shabbir U, Chen X, et al. Phytochemical profiling and cellular antioxidant efficacy of different rice varie- ties in colorectal adenocarcinoma cells exposed to oxidative stress. PloS One. 2022;17:e0269403. doi: 10.1371/ journal.pone.0269403
Goufo P, Trindade H. Rice antioxidants: phenolic acids, flavonoids, anthocyanins, proanthocyanidins, tocophe- rols, tocotrienols, γ-oryzanol, and phytic acid. Food Sci Nutr. 2014;2:75-104. doi: 10.1002/fsn3.86
Gunaratne A, Wu K, Li D, Bentota A, Corke H, Cai YZ. Antioxidant activity and nutritional quality of traditional red-grained rice varieties containing proanthocyanidins. Food Chem. 2013;138:1153-1161. doi: 10.1016/j.food- chem.2012.11.129
Sapna I, Jayadeep A. Influence of enzyme concentrations in enzymatic bioprocessing of red rice bran: A detailed study on nutraceutical compositions, antioxidant and human LDL oxidation inhibition properties. Food Chem. 2021;351:129272. doi: 10.1016/j.foodchem.2021.129272
Ghasemzadeh A, Baghdadi A, Z E Jaafar H, et al. Optimization of flavonoid extraction from red and brown rice bran and evaluation of the antioxidant properties. Molecules. 2018;23:E1863. doi: 10.3390/molecules23081863
Boue SM, Daigle KW, Chen MH, et al. Antidiabetic potential of purple and red rice (Oryza sativa L.) bran ex- tracts. J Agric Food Chem. 2016;64:5345–5353. doi: 10.1021/acs.jafc.6b01909
Tan XW, Kobayashi K, Shen L, et al. Antioxidative attributes of rice bran extracts in ameliorative effects of athero- sclerosis-associated risk factors. Heliyon. 2020;6: e05743. doi: 10.1016/j.heliyon.2020.e05743
Limtrakul P, Yodkeeree S, Pitchakarn P, Punfa W. Anti-inflammatory effects of proanthocyanidin-rich red rice extract via suppression of MAPK, AP-1 and NF-κB pathways in Raw 264.7 macrophages. Nutr Res Pract. 2016;10:251-258. doi: 10.4162/nrp.2016.10.3.251
Surarit W, Jansom C, Lerdvuthisopon N, et al. Evaluation of antioxidant activities and phenolic subtype contents of ethanolic bran extracts of Thai pigmented rice varieties through chemical and cellular assays. Int J Food Sci Technol. 2015;50:990-998. doi: 10.1111/IJFS.12703
Chen MH, Choi SH, Kozukue N, et al. Growth-inhibitory effects of pigmented rice bran extracts and three red bran fractions against human cancer cells: relationships with composition and antioxidative activities. J Agric Food Chem. 2012;60:9151-9161. doi: 10.1021/jf3025453
Ghasemzadeh A, Karbalaii MT, Jaafar HZE, Rahmat A. Phytochemical constituents, antioxidant activity, and antiproliferative properties of black, red, and brown rice bran. Chem Cent J. 2018;12:17. doi: 10.1186/s13065-018- 0382-9
Upanan S, Yodkeeree S, Thippraphan P, et al. The proanthocyanidin-rich fraction obtained from red rice germ and bran extract induces HepG2 hepatocellular carcinoma cell apoptosis. Molecules. 2019;24:813. doi: 10.3390/ molecules24040813
OECD. Test No. 487: In Vitro Mammalian Cell Micronucleus Test [Internet]. Paris: Organisation for Economic Co-operation and Development; 2016 [cited 2022 Aug 21]. Available from: https://www.oecd-ilibrary.org/envi- ronment/test-no-487-in-vitro-mammalian-cell-micronucleus-test_9789264264861-en
World Health Organization. WHO traditional medicine strategy: 2014-2023 [Internet]. World Health Organiza- tion; 2013 [cited 2022 Aug 21]. 76 p. Available from: https://apps.who.int/iris/handle/10665/92455
Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395-417. doi: 10.1038/s41571-020-0341-y
Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000;21:485-495. doi: 10.1093/carcin/21.3.485
Araldi RP, de Melo TC, Mendes TB, et al. Using the comet and micronucleus assays for genotoxicity studies: A review. Biomed Pharmacother. 2015;72:74-82. doi: 10.1016/j.biopha.2015.04.004
Fenech M. Cytokinesis-block micronucleus cytome assay. Nat Protoc. 2007;2:1084-1104. doi: 10.1038/ nprot.2007.77
Ratanavalachai T, Thitiorul S, Tanuchit S, et al. Antigenotoxic activity of Thai Sangyod red rice extracts against a chemotherapeutic agent, doxorubicin, in human lymphocytes by sister chromatid exchange (SCE) assay in vi- tro. J Med Assoc Thail Chotmaihet Thangphaet. 2012;95:109-114. Suppl 1:S109-S114
Submitted: October 03, 2022
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Experimental Oncology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.